Lantheus Announces Executive Team Reshuffle with New CSO
Company Announcements

Lantheus Announces Executive Team Reshuffle with New CSO

Lantheus (LNTH) has provided an announcement.

Lantheus Holdings, Inc. has announced a significant change in their executive team, with Jean-Claude Provost MD transitioning from Chief Medical Officer to the role of Chief Science Officer effective May 28, 2024. This strategic move aims to leverage Dr. Provost’s expertise in a new capacity, signaling a potential shift in the company’s focus and priorities that could intrigue investors and market watchers.

For an in-depth examination of LNTH stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyLantheus price target raised to $137 from $128 at JonesResearch
GlobeNewswireLantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
GlobeNewswireLantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!